Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial
Thank you for registering! Take a moment to confirm your subscription to MarketBeat Daily Ratings so that you can access MarketBeat's tools, reports, and news. Please click the "Send Confirmation Email" button and we'll send you an email with confirmation instructions.
Send Confirmation Email
NASDAQ:SNMX

Senomyx (SNMX) Stock Price, News & Analysis

→ Crypto Pioneer Says: “The last crypto bull market has begun.” (From InvestorPlace) (Ad)
Free SNMX Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$1.49
▼
$1.49
50-Day Range
N/A
52-Week Range
$0.83
▼
$1.71
Volume
N/A
Average Volume
151,720 shs
Market Capitalization
$72.03 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
SNMX stock logo

About Senomyx Stock (NASDAQ:SNMX)

Senomyx, Inc. discovers, develops, and commercializes flavor ingredients and natural high intensity sweeteners primarily for the packaged food, beverage, and ingredient supply industries in the United States. The company develops and/or commercializes sweet, savory and salt flavor ingredients, bitter blockers and cooling agents. It sells various flavor ingredients directly to flavor companies. The company has collaboration agreements with Ajinomoto Co., Inc.; Firmenich SA; and PepsiCo, Inc. Senomyx, Inc. was founded in 1998 and is headquartered in San Diego, California.

SNMX Stock News Headlines

May 18 at 6:18 PM | morningstar.com
Disty Technologies DYT
December 9, 2023 | morningstar.com
AKD Securities Ltd Ordinary Shares AKDSL
July 19, 2023 | investing.com
NZ Automotive Investments Ltd (NZA)
March 30, 2023 | thestreet.com
McKesson Inc. (MCK): Today's Featured Wholesale Laggard
February 23, 2023 | usatoday.com
Fact check: Fetal tissue not in your food, drinks, experts say
June 2, 2022 | thestreet.com
How to Get Stock Exposure to Gluten-Free Movement
January 29, 2022 | fool.com
Senomyx, Inc.(SNMX)
See More Headlines

Company Calendar

Last Earnings
8/02/2018
Today
5/20/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Consumer Staples
Industry
Commercial Physical Research
Sub-Industry
N/A
Current Symbol
NASDAQ:SNMX
CUSIP
N/A
CIK
1123979
Web
www.senomyx.com
Phone
858-646-8300
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($0.03)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-1,260,000.00
Net Margins
-9.11%
Pretax Margin
N/A
Return on Equity
-15.80%
Return on Assets
-10.48%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.35
Quick Ratio
3.92

Sales & Book Value

Annual Sales
$29.32 million
Price / Sales
2.46
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.39 per share
Price / Book
3.82

Miscellaneous

Outstanding Shares
48,340,000
Free Float
N/A
Market Cap
$72.03 million
Optionable
Optionable
Beta
1.33

Key Executives

  • Mr. John W. Poyhonen (Age 58)
    Pres, CEO & Director
  • Mr. David C. Humphrey (Age 49)
    VP & CFO
  • Ms. Catherine C. Lee (Age 44)
    Sr. VP, Gen. Counsel & Corp. Sec.
  • Ms. Sharon Wicker (Age 62)
    Sr. VP & Chief Commercial Devel. Officer
  • Ms. Susan Firestone Melody
    VP of HR

Key Competitors

View All Competitors

SNMX Stock Analysis - Frequently Asked Questions

How were Senomyx's earnings last quarter?

Senomyx, Inc. (NASDAQ:SNMX) announced its quarterly earnings data on Thursday, August, 2nd. The specialty chemicals company reported ($0.08) earnings per share for the quarter, beating analysts' consensus estimates of ($0.09) by $0.01. The specialty chemicals company earned $3.29 million during the quarter. Senomyx had a negative net margin of 9.11% and a negative trailing twelve-month return on equity of 15.80%.

What other stocks do shareholders of Senomyx own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Senomyx investors own include Aralez Pharmaceuticals (ARLZ), Heron Therapeutics (HRTX), Novavax (NVAX), Rexahn Pharmaceuticals (REXN), Vical (VICL), (CASC) (CASC), DURECT (DRRX), Idera Pharmaceuticals (IDRA), Inovio Pharmaceuticals (INO) and Lexicon Pharmaceuticals (LXRX).

This page (NASDAQ:SNMX) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners
Shocking: One AI startup's revenue could surge 4,735%
Manward Press
The Overlooked Retirement Asset You Probably Don’t Own
Crypto 101 Media
Next President (Not Trump. Not Biden.)
The Freeport Society
Urgent Nvidia Warning
Altimetry
Elon’s New Device is About to Shock the World
InvestorPlace
"The Biggest Drug Ever" Is Coming
Behind the Markets
CEO of Biggest AI Chipmaker Just Dropped a Bombshell…
Banyan Hill Publishing
Exposed: 10 CENT Crypto to Explode May 20th?
True Market Insiders